MedPath

Study on the concentration of methotrexate polyglutamates in erythrocytes for the purpose of formulating the evidence-based guideline of diagnosis and treatment on juvenile idiopathic arthritis

Not Applicable
Conditions
Juvenile idiopathic arthritis
Registration Number
JPRN-UMIN000027373
Lead Sponsor
Department of lifetime clinical immunology, Graduate school of medical and dental sciences, Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who was prescribed increasing or decreasing dose of methotrexate in 4 weeks. Patients who was prescribed other immunosuppressants. Patients that the consent to enroll in this study was not obtained.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath